« Back to Record
Citation APA

Le Calve, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (New York, N.Y.), 12(9), 727-739. doi:10.1593/neo.10526


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/68382

Le Calve, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (New York, N.Y.), 12(9), 727-739. doi:10.1593/neo.10526